Kyowa Kirin CoKYKOF 82 PS Ratio is 2.24 as of Jun. 30, 2026, which is 38% below its 10-year median of 3.59. GuruFocus rates KYKOF with a GF Score™ of 82/100 and a GF Value™ of $16.79 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 948 Drug Manufacturers companies, Kyowa Kirin Co ranks worse than 56.43% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Kyowa Kirin Co's share price is $14.425.
Kyowa Kirin Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $6.43. Hence, Kyowa Kirin Co's PS Ratio for today is 2.24.
The historical rank and industry rank for Kyowa Kirin Co's PS Ratio or its related term are showing as below:
KYKOF'
s PS Ratio Range Over the Past 10 Years
Min: 2.18 Med: 3.59 Max: 6.95
Current: 2.61
During the past 13 years, Kyowa Kirin Co's highest PS Ratio was 6.95. The lowest was 2.18. And the median was 3.59.
KYKOF's PS Ratio is ranked worse than 56.43% of 948
companies
in the Drug Manufacturers industry
Industry Median: 2.205
vs KYKOF: 2.61
Kyowa Kirin Co Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Kyowa Kirin Co was 1.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 8.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 10.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 4.60% per year.
During the past 13 years, Kyowa Kirin Co's highest 3-Year average Revenue per Share Growth Rate was 12.60% per year. The lowest was -15.00% per year. And the median was 0.10% per year.
Back to Basics: PS Ratio
Kyowa Kirin Co (OTCPK:KYKOF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Kyowa Kirin Co PS Ratio Related Terms
Kyowa Kirin Co PS Ratio Historical Data
* Premium members only.
The historical data trend for Kyowa Kirin Co's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Kyowa Kirin Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kyowa Kirin Co PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kyowa Kirin Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Kyowa Kirin Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Kyowa Kirin Co's Share Price of today is $14.425. Kyowa Kirin Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.43.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Kyowa Kirin Co (KYKOF) has a PS Ratio of 2.24 as of Jun. 30, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Kyowa Kirin Co and its competitors. This is 38% below median its historical median of 3.59. Over the past decade, Kyowa Kirin Co's PS Ratio has ranged from 2.18 to 6.95. According to the industry distribution chart, Kyowa Kirin Co ranks #535 out of 948 companies in the Drug Manufacturers industry, placing it in the top 56.4%.
Is Kyowa Kirin Co's PS Ratio too high?
Kyowa Kirin Co's current PS Ratio of 2.24 is 38% below median its 10-year median of 3.59. Over the past 10 years, this metric has ranged from a low of 2.18 to a high of 6.95. The Drug Manufacturers industry median PS Ratio is 2.21. Kyowa Kirin Co's value of 2.24 is 1.6% above this industry median. Based on the distribution chart, Kyowa Kirin Co ranks #535 out of 948 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Kyowa Kirin Co has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kyowa Kirin Co's PS Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kyowa Kirin Co ranks #535 out of 948 companies for PS Ratio. This places Kyowa Kirin Co in the lower half of its industry. The industry median PS Ratio is 2.21. Kyowa Kirin Co's value of 2.24 is 1.6% above this benchmark. Historically, Kyowa Kirin Co's own PS Ratio has ranged from 2.18 to 6.95 over the past decade. While the company's 10-year median is 3.59 vs. the industry median of 2.21, Kyowa Kirin Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.21, based on 948 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kyowa Kirin Co's current PS Ratio of 2.24 is 1.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Kyowa Kirin Co and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kyowa Kirin Co's current PS Ratio is 2.24, which is 38% below median its own 10-year median of 3.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kyowa Kirin Co stock overvalued right now?
Based on GuruFocus' analysis, Kyowa Kirin Co (KYKOF) is currently considered Modestly Undervalued. The stock's GF Value™ is $16.79, compared to a current price of $14.43 — trading 14.1% below its estimated fair value. The current PS Ratio is 2.24, which is 38% below median its 10-year median of 3.59 and 1.6% above the Drug Manufacturers industry median of 2.21. Kyowa Kirin Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Kyowa Kirin Co (KYKOF), the current PS Ratio is 2.24 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kyowa Kirin Co (KYKOF) Overvalued in 2026?
Based on GuruFocus' analysis, Kyowa Kirin Co stock appears to be undervalued.
The current stock price of $14.43 is trading 14.1% below its estimated GF Value™ of $16.79.
GuruFocus considers Kyowa Kirin Co to be Modestly Undervalued.
Key valuation signals for KYKOF:
PS Ratio: 2.24 (38% below median its 10-year median of 3.59)
GF Value™: $16.79 vs. price of $14.43 (14.1% below fair value)
Industry Position: 1.6% above the Drug Manufacturers median (#535 of 948)
No single metric tells the full story. See the KYKOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kyowa Kirin Co Ltd is engaged in research, development, manufacturing, sales, import and export of prescription pharmaceuticals. Its products include KHK4083/AMG 451, rocatinlimab; ziftomenib; OTL-203 KK8398, infigratinib; KHK4951, tivozanib; OTL-201; KK4277; KK2260; KK2269; KK2845; and KK8123.
82GF Score
Get the complete analysis for KYKOF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KYKOF has been successfully added to your 
